KMT2A and acute myeloid leukemia: For instance, the MLL-AF9 (KMT2A-MLLT3) fusion, associated with up to 5% of adult AML and in 25% of de novo AML in children [4], initiates transformation in rapidly cycling myeloid progenitors [7].